Catalyst

Slingshot members are tracking this event:

Janssen's (JNJ) Yondelis for Soft Tissue Sarcomas Approved By FDA

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
JNJ

100%
Slingshot Insights Explained
Catalyst Date
Occurred on:
Oct 23, 2015
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Yondelis, Soft Tissue Sarcomas, Liposarcoma, Leiomyosarcoma